ACOR
Acorda Therapeutics
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
174 hedge funds and large institutions have $1.52B invested in Acorda Therapeutics in 2014 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 63 increasing their positions, 58 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
3% more capital invested
Capital invested by funds: $1.47B → $1.52B (+$46.9M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
174
Holding in Top 10
1
Calls
$13.3M
Puts
$8.31M
Top Buyers
| 1 | +$45.7M | |
| 2 | +$41.5M | |
| 3 | +$33.9M | |
| 4 |
VAM
Visium Asset Management
New York
|
+$18M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$12.2M |
Top Sellers
| 1 | -$22.8M | |
| 2 | -$20.8M | |
| 3 | -$15.7M | |
| 4 |
Millennium Management
New York
|
-$14.3M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$12.8M |